Radiocontrast-induced nephropathy

Current status and future prospects

K. Margulies, J. Schirger, John C Jr. Burnett

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Radiocontrast-induced nephropathy (RCIN), a leading cause of in-hospital acute renal failure, is an acute decrease in renal function related to intravascular administration of iodinated radiocontrast agents. Though RCIN is relatively uncommon in patients without predisposing factors, patients with preexisting renal dysfunction, diabetes mellitus and severe congestive heart failure are at increased risk for acute renal failure following radiocontrast. Three recently developed animal models have provided important insights into the pathophysiology of RCIN. Specifically, these studies have implicated transient renal ischemia, direct renal tubular toxicity and changes in glomerular capillary permeability as possible mediators of RCIN, and these pathophysiologic mechanisms are not mutually exclusive. There is currently no effective treatment for RCIN. Assuring adequate hydration may reduce the risk of RCIN. In addition, synthetic atrial natriuretic factor and/or mannitol are promising, but as yet unproven, approaches to the prophylaxis of RCIN.

Original languageEnglish (US)
Pages (from-to)20-25
Number of pages6
JournalInternational Angiology
Volume11
Issue number1
StatePublished - 1992

Fingerprint

Kidney
Acute Kidney Injury
Capillary Permeability
Atrial Natriuretic Factor
Mannitol
Causality
Contrast Media
Diabetes Mellitus
Ischemia
Animal Models
Heart Failure
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Radiocontrast-induced nephropathy : Current status and future prospects. / Margulies, K.; Schirger, J.; Burnett, John C Jr.

In: International Angiology, Vol. 11, No. 1, 1992, p. 20-25.

Research output: Contribution to journalArticle

@article{a4965ec5e54b41f49462e0be49474e2b,
title = "Radiocontrast-induced nephropathy: Current status and future prospects",
abstract = "Radiocontrast-induced nephropathy (RCIN), a leading cause of in-hospital acute renal failure, is an acute decrease in renal function related to intravascular administration of iodinated radiocontrast agents. Though RCIN is relatively uncommon in patients without predisposing factors, patients with preexisting renal dysfunction, diabetes mellitus and severe congestive heart failure are at increased risk for acute renal failure following radiocontrast. Three recently developed animal models have provided important insights into the pathophysiology of RCIN. Specifically, these studies have implicated transient renal ischemia, direct renal tubular toxicity and changes in glomerular capillary permeability as possible mediators of RCIN, and these pathophysiologic mechanisms are not mutually exclusive. There is currently no effective treatment for RCIN. Assuring adequate hydration may reduce the risk of RCIN. In addition, synthetic atrial natriuretic factor and/or mannitol are promising, but as yet unproven, approaches to the prophylaxis of RCIN.",
author = "K. Margulies and J. Schirger and Burnett, {John C Jr.}",
year = "1992",
language = "English (US)",
volume = "11",
pages = "20--25",
journal = "International Angiology",
issn = "0392-9590",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Radiocontrast-induced nephropathy

T2 - Current status and future prospects

AU - Margulies, K.

AU - Schirger, J.

AU - Burnett, John C Jr.

PY - 1992

Y1 - 1992

N2 - Radiocontrast-induced nephropathy (RCIN), a leading cause of in-hospital acute renal failure, is an acute decrease in renal function related to intravascular administration of iodinated radiocontrast agents. Though RCIN is relatively uncommon in patients without predisposing factors, patients with preexisting renal dysfunction, diabetes mellitus and severe congestive heart failure are at increased risk for acute renal failure following radiocontrast. Three recently developed animal models have provided important insights into the pathophysiology of RCIN. Specifically, these studies have implicated transient renal ischemia, direct renal tubular toxicity and changes in glomerular capillary permeability as possible mediators of RCIN, and these pathophysiologic mechanisms are not mutually exclusive. There is currently no effective treatment for RCIN. Assuring adequate hydration may reduce the risk of RCIN. In addition, synthetic atrial natriuretic factor and/or mannitol are promising, but as yet unproven, approaches to the prophylaxis of RCIN.

AB - Radiocontrast-induced nephropathy (RCIN), a leading cause of in-hospital acute renal failure, is an acute decrease in renal function related to intravascular administration of iodinated radiocontrast agents. Though RCIN is relatively uncommon in patients without predisposing factors, patients with preexisting renal dysfunction, diabetes mellitus and severe congestive heart failure are at increased risk for acute renal failure following radiocontrast. Three recently developed animal models have provided important insights into the pathophysiology of RCIN. Specifically, these studies have implicated transient renal ischemia, direct renal tubular toxicity and changes in glomerular capillary permeability as possible mediators of RCIN, and these pathophysiologic mechanisms are not mutually exclusive. There is currently no effective treatment for RCIN. Assuring adequate hydration may reduce the risk of RCIN. In addition, synthetic atrial natriuretic factor and/or mannitol are promising, but as yet unproven, approaches to the prophylaxis of RCIN.

UR - http://www.scopus.com/inward/record.url?scp=0026632620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026632620&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 20

EP - 25

JO - International Angiology

JF - International Angiology

SN - 0392-9590

IS - 1

ER -